Search:
   

Wednesday, June 21, 2017

Equity Trader Alert #2017 - 137
(UPDATED) Information regarding the Tender Offer and Change of Incorporation for Nabriva Therapeutics AG (NBRV)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:

On May 23, 2017, Nabriva Therapeutics AG (NBRV) commenced a tender offer to exchange each Nabriva Therapeutics AG ADS for one Nabriva Therapeutics Plc Ordinary Share. In addition to the tender offer the company is changing its place of incorporation from Austria to Ireland. The Exchange Offer will expired at 5:00 P.M. on June 23, 2017. The transaction will become effective on June 26, 2017.

The details are as follows; Please note the symbol will remain the same.

Current Company Name: Nabriva Therapeutics AG
Current Issue: American Depositary Shares
Current CUSIP: 62957M104
Current Domicile: Austria
Current Par Value: N/A
New Company Name: Nabriva Therapeutics Plc
New Issue: Ordinary Shares
New CUSIP: G63637105
New Domicile: Ireland
New Par Value: .01
Marketplace Effective Date: June 26, 2017


If you would like to register as a market maker in NBRV, contact Nasdaq Trading Services at +1 212 231 5100.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile